Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Pandemic Vaccines

1594

The occurrence of pandemics highlights the need for proper vaccination. Despite ongoing improvements in pediatric vaccination, it is estimated that at least two million children die each year from diseases that could have been prevented by already existing vaccines. This problem is most significant in low income countries, with the health disparity between rich and poor countries resulting in average life spans of 77 and 52 years, respectively.
In many developed regions, such as the United States, disease prevention by immunization is a public health priority for both pediatricians and society as a whole. Comprehensive and timely immunization of young children has been a major goal of pediatric healthcare. Today, several government organizations are involved in reviewing and updating pediatric vaccine programs. As a result of the success of vaccination and immunization programs, several debilitating infectious diseases have been controlled.

A wide variety of vaccine products are currently recommended to immunize children against disease. Immunizations by public providers are generally paid for through federal health programs. These programs are intended to reduce barriers to immunization and to improve immunization rates by providing free vaccines to qualifying infants and children.

There have been and will continue to be challenges to the vaccine delivery system in terms of the science, economics, and social impact of immunization; these challenges may increase as new vaccines are developed. For example, shortages of specific vaccines continue to occur, in both the developed and developing nations, and have resulted in significant disruption to childhood immunizations. Another significant challenge to immunization delivery is the increasing concern within a segment of the general public about the safety and potential adverse effects of childhood immunizations.

Adult immunization is an important, but frequently overlooked, part of patient care. Vaccination programs typically focus on children, yet adults in industrialized countries are more likely to die as a result of vaccine-preventable diseases than are children. Vaccination protects not only individuals, but also entire communities from diseases spread by person-to-person transmission.

RSS Feeds

All reports in Pandemic Vaccines

< prev 1  2  next >
Research Report on Chinese Bio-pharmaceutical Industry, 2012
3/21/2012 | published by: China Research and Intelligence Co., Ltd.
... bio-pharmaceutical industry. "Bio-pharmaceutical" in the report only refers to human biological products. Chinese biological product industry is an emerging industry which has only over 20 years of history. In 2011, the sales revenue of Chinese ...  |  more...
$3,000.00
Human Vaccines
3/1/2012 | published by: Global Industry Analysts
... Japan, Europe, Asia-Pacific, Middle East and Latin America. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report also analyzes the ...  |  more...
$4,500.00
Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2012-2022
2/15/2012 | published by: Visiongain
... new study lets you assess prominent companies in the pre-filled (ready-to-fill) syringe industry and market from 2012 to 2022. There you find analytical profiles for leading companies - activities, outlooks and prospects: Becton, Dickinson & ...  |  more...
$2,642.00
Vaccine Production (Trends, Techniques, Key Players, Spending Estimates and Forecasts)
2/1/2012 | published by: Kalorama Information
... Is vaccine-making profitable? How much is the industry spending? How much is handed off to other companies and how much is made by the branded manufacturers? How many doses are produced by the industry? These ...  |  more...
$2,500.00
Needle-Free Delivery: Technology and Market 2012-2022
1/24/2012 | published by: Visiongain
... by the need for pain free delivery. Currently, the market for needle-free delivery devices is dominated by small medical device companies and academic researchers. These small scale companies are developing innovative needle-free delivery technologies, with ...  |  more...
$2,642.00
Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast
1/5/2012 | published by: Renub Research
... been at the forefront of this trend, partially fuelled by the fear of an impending pandemic. As a result global influenza vaccine market has experienced phenomenal growth in recent years at a compound annual growth ...  |  more...
$1,100.00
Seasonal Influenza Vaccine Market in Asia-Pacific Region - Cell Culture Technology-Based Vaccines to Revolutionize the Market by Faster Production and High Initial Purity
12/14/2011 | published by: GBI Research
... research “Seasonal Influenza Vaccine Market in Asia-Pacific Region - Cell Culture Technology-Based Vaccines to Revolutionize the Market by Faster Production and High Initial Purity Description” which essentially provides insights into the seasonal influenza vaccine sales ...  |  more...
$3,500.00
H1N1 Infection (Swine Influenza) - Pipeline Review, H2 2011
10/26/2011 | published by: Global Markets Direct
... provides information on the therapeutic development for H1N1 Infection (Swine Influenza), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H1N1 ...  |  more...
$500.00
Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018
10/11/2011 | published by: GlobalData
... is an essential source of information and analysis on the global influenza vaccines market. The report identifies the key trends shaping and driving the global influenza vaccines market. The report also provides insights on the ...  |  more...
$3,500.00
Epidemiology: Influenza – Incident cases expected to remain stable due to low vaccination rates
10/5/2011 | published by: Datamonitor
... markets covered. Introduction Datamonitor epidemiologists forecast that in 2011 there will roughly 107.51 million incident cases of seasonal influenza in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK), and ...  |  more...
$3,800.00
Epidemiology: Influenza - Incident cases expected to remain stable due to low vaccination rates
10/5/2011 | published by: Datamonitor
... cases are predicted for 2021. The number of incident cases of seasonal influenza is expected to remain fairly stable throughout the forecast period.Gain insight into market potential, including a robust 10-year epidemiology forecast of seasonal ...  |  more...
$3,800.00
Global Influenza Vaccine Market Analysis
10/1/2011 | published by: RNCOS
... pandemics are still present in the environment, and in the coming future, they may be classified as strains to be updated in seasonal vaccines. Moreover, a large chunk of global population is affected by influenza-related ...  |  more...
$1,200.00
R&D Trends: Influenza vaccines - Commoditization limits opportunities in a crowded market
8/5/2011 | published by: Datamonitor
... novel technologies might struggle against the uncertainty regarding the next pandemic influenza strain and the increasing commoditization of the influenza markets. Features and benefits Discussion of seasonal, pandemic and universal influenza vaccine pipelines Analysis of ...  |  more...
$395.00
Strategic Analysis of Emerging Vaccines Market in India
6/30/2011 | published by: Frost & Sullivan
... analysis of industry challenges, market drivers and market restraints, and how they impact the market dynamics during the forecast period. Further, market drivers and restraints for each vaccine is covered in the report. A market ...  |  more...
$6,000.00
Competitor Analysis: Influenza Vaccines
5/1/2011 | published by: La Merie Publishing
... the manufacturing process: propagated in hens’ eggs or in cell culture, recombinant protein based vaccines and DNA based vaccines. Product description considers use of adjuvants and preservatives. Vaccines with nasal delivery are highlighted. Purchase of ...  |  more...
$718.00
Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market
4/11/2011 | published by: GBI Research
... research, “Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market”, which provides insights into the global travel vaccines market and market ...  |  more...
$3,500.00
H1N1 (Swine Influenza) - Pipeline Review, Q1 2011
3/29/2011 | published by: Global Markets Direct
... the therapeutic development for H1N1 (Swine Influenza), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H1N1 (Swine Influenza). 'H1N1 (Swine ...  |  more...
$500.00
Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of Asia
3/25/2011 | published by: Kalorama Information
... people throughout Asia accounts for more than half of the global population, yet currently it is Western markets which lead vaccine sales. This hasn't stopped companies from investing in Asian vaccine markets. The graying of ...  |  more...
$3,500.00
The PATH Malaria Vaccine Initiative (MVI)-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... accurate, current and comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. ...  |  more...
$750.00
H1N1 (Swine Influenza) - Pipeline Assessment and Market Forecasts to 2017
3/1/2011 | published by: GlobalData
... is an essential source of information and analysis on the global H1N1 (Swine Influenza) Therapeutics market. The report identifies the key trends shaping and driving the global H1N1 (Swine Influenza) Therapeutics market. The report also ...  |  more...
$2,000.00
Special Report: Next-Generation Infectious Disease Vaccines—Novel Technologies and Opportunities
3/1/2011 | published by: Decision Resources
... such as virus-like particles, recombinant vaccines, cellular expression systems, and DNA vaccines, is fueling the pharmaceutical industry's interest in the vaccine market and providing lucrative opportunities for companies with novel technologies and experimental candidates. Questions ...  |  more...
$4,600.00
World Influenza Vaccines Market 2011-2021
2/7/2011 | published by: Visiongain
... will see commercial opportunities for influenza vaccines - original research, data and opinions. By ordering now, you can stay ahead. We aim to save you time and aid your decisions. Our report shows revenue opportunities ...  |  more...
$2,331.00
Seasonal Influenza Vaccine Market in Asia - Pacific Region - Threat of Pandemic Influenza and Increasing Vaccination Coverage to Drive Growth
1/6/2011 | published by: GBI Research
... Influenza Vaccine Market in Asia-Pacific Region-Threat of Pandemic Influenza and Increasing Vaccination Coverage to Drive Growth” which essentially provides insights on seasonal influenza vaccine sales forecasts for the Asia-Pacific Region until 2016. The report also ...  |  more...
$3,500.00
H1N1 (Swine Influenza) - Pipeline Review, Q4 2010
12/29/2010 | published by: Global Markets Direct
... on the therapeutic development for H1N1 (Swine Influenza) Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H1N1 (Swine Influenza) ...  |  more...
$500.00
European Vaccine Markets: Germany, UK, France, Spain, Italy, Rest of Europe
11/1/2010 | published by: Kalorama Information
... products. This has encouraged market participants to increase spending in research and development. This report, European Vaccine Markets , examines the market for vaccines used in humans for various types of disease. It covers only ...  |  more...
$995.00
< prev 1  2  next >